OneSpan OSPN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains on Profitability Beat Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported AEON Biopharma Inc AEON Q4 2025 Earnings Significant EPS Miss and Stock Decline Amid Development Challenges Profound Medical Q1 2026 Earnings EPS Beats Estimates Stock Declines XOMA Q1 2026 Earnings EPS Misses Estimates as Royalty Revenue Falls Short MIRA Q3 2025 Earnings Narrowed Loss Surpasses Expectations Amid No Revenue